aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate.

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures..

for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.medical information:

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome).

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. it may also be used to treat or prevent low blood potassium.long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).short-term preoperative treatment of patients with primary hyperaldosteronism

aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial.. it may also be used to treat or prevent low blood potassium.product origin: eu (turkey)

this product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. all products are authentic brand names and will include a product information insert in english.short-term preoperative treatment of patients with primary hyperaldosteronism.

medical information:

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome).

for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate.

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures.

aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial.

for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response. aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate.short-term preoperative treatment of patients with primary hyperaldosteronism.medical information:

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome). it is also used for treatment of high blood pressure.

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome).

for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.short-term preoperative treatment of patients with primary hyperaldosteronism. aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate.long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery.. it may also be used to treat or prevent low blood potassium.

aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. it is also used for treatment of high blood pressure.

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures